Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease

    FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease

    FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

    Start listeningView podcast show

    FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease

    FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

    ratings:
    Length:
    14 minutes
    Released:
    May 31, 2024
    Format:
    Podcast episode

    Description

    To celebrate the FLOW trial and break down what it means for people with type 2 diabetes and CKD, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, recorded a special edition episode to discuss the clinical application of this trial, unmet need in CKD management, the future of incretin therapies, and more!

    Chapters:
    00:00 - Intro 
    00:40 - FLOW Background
    02:55 - FLOW Results
    07:08 - Combination with SGLT2 Inhibitors
    12:00 - Future Implications
    Released:
    May 31, 2024
    Format:
    Podcast episode

    Titles in the series (97)

    Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at http://HCPLive.com/Clinical/Endocrinology. Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com. Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.